Cargando…

Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients

PURPOSE: This study was conducted to evaluate the systemic inflammatory response in colorectal cancer patients, and to estimate the usefulness of the Glasgow prognostic score (GPS) as a prognostic factor. METHODS: Patients with biopsy-proven colorectal adenocarcinoma who were operated between April...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Kyeong Woon, Hong, Seong Woo, Chang, Yeo Goo, Lee, Woo Yong, Lee, Byungmo, Paik, In Wook, Lee, Hyucksang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Surgical Society 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062449/ https://www.ncbi.nlm.nih.gov/pubmed/24949322 http://dx.doi.org/10.4174/astr.2014.86.6.309

Ejemplares similares

Matrix Metalloproteinase-2 and -7 Expression in Colorectal Cancer
por: Hong, Seong Woo, et al.
Publicado: (2011)

Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
por: Hong, Injae, et al.
Publicado: (2015)

Inflammation-based Glasgow prognostic score as an independent prognostic factor in patients with angioimmunoblastic T-cell lymphoma
por: Chen, Guan-Jun, et al.
Publicado: (2021)

Carcinosarcoma of the Stomach: A Case Report
por: Choi, Kyeong Woon, et al.
Publicado: (2013)

The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
por: Kinoshita, Akiyoshi, et al.
Publicado: (2013)

Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer
por: Jiang, X, et al.
Publicado: (2012)

Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter
por: Yamada, Suguru, et al.
Publicado: (2016)

Prognostic Inflammation Score in Surgical Patients with Colorectal Cancer
por: Seong, Moo-Kyung
Publicado: (2015)

Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis
por: Lu, Lingling, et al.
Publicado: (2021)

Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score
por: Hirahara, Noriyuki, et al.
Publicado: (2020)

Validation of the conventional Glasgow Prognostic Score and development of the improved Glasgow Prognostic Score in patients with stage 0‐III colorectal cancer after curative resection
por: Ishikawa, Satoshi, et al.
Publicado: (2021)

The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction
por: Jomrich, Gerd, et al.
Publicado: (2018)

The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer
por: Hanai, Nobuhiro, et al.
Publicado: (2018)

Prognostic role of Glasgow prognostic score in patients with colorectal cancer: evidence from population studies
por: Liu, Yangyang, et al.
Publicado: (2017)

Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients
por: Lu, Xin, et al.
Publicado: (2018)

The Inflammation-Based Glasgow Prognostic Score as a Prognostic Factor in Patients with Intensive Cardiovascular Care Unit
por: Altay, Servet, et al.
Publicado: (2019)

A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
por: Tong, Tongyu, et al.
Publicado: (2020)

Clinical Significance of Preoperative Inflammatory Parameters in Gastric Cancer Patients
por: Lee, Deuk Young, et al.
Publicado: (2013)

Glasgow prognostic score and combined positive score for locally advanced rectal cancer
por: Feng, Yanru, et al.
Publicado: (2022)

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
por: Proctor, M J, et al.
Publicado: (2011)

Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer
por: Omichi, Chiaki, et al.
Publicado: (2016)

Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma
por: Hao, Xiaoxiao, et al.
Publicado: (2017)

The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma
por: Tian, Rui, et al.
Publicado: (2016)

Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score
por: Nakamura, Tomoki, et al.
Publicado: (2022)

Clinical Impact of Combined Modified Glasgow Prognostic Score and C-Reactive Protein/Albumin Ratio in Patients with Colorectal Cancer
por: Son, Woosung, et al.
Publicado: (2020)

Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis
por: Shin, Jung Kyong, et al.
Publicado: (2022)

Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer
por: Zhou, Jiahui, et al.
Publicado: (2021)

The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma
por: Inamoto, Teruo, et al.
Publicado: (2017)

External validation of the modified Glasgow prognostic score for renal cancer
por: Tai, Caroline G., et al.
Publicado: (2014)

Glasgow Prognostic Score as a Marker of Mortality after TAVI
por: Abacioglu, Ozge Ozcan, et al.
Publicado: (2021)

The Modified Glasgow Prognostic Score Is an Independent Prognostic Factor in Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
por: Zhang, Peng, et al.
Publicado: (2014)

CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70—A Retrospective Study
por: Messerich, Nora-Medea, et al.
Publicado: (2023)

The Modified Glasgow Prognostic Score as a Predictor of Survival After Hepatectomy for Colorectal Liver Metastases
por: Nakagawa, Kazuya, et al.
Publicado: (2014)

Sarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients
por: Aro, Raila, et al.
Publicado: (2022)

The inflammation‐based modified Glasgow prognostic score is associated with survival in stable heart failure patients
por: Cho, Anna, et al.
Publicado: (2020)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
por: Zhang, Huan, et al.
Publicado: (2020)

Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma
por: Park, Hyung Soon, et al.
Publicado: (2016)

Synchronous T-cell lymphoma in patient with colon cancer: a case report
por: Lee, Deuk Young, et al.
Publicado: (2012)

Inflammatory myofibroblastic tumor mimicking hepatocellular carcinoma with dense lipiodol uptake
por: Hong, Seong Woo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rn0vpb8nvb9d70cj0to6u5f8dd